Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 9:56 PM
Ignite Modification Date: 2025-12-24 @ 9:56 PM
NCT ID: NCT01320332
Eligibility Criteria: Inclusion Criteria: * Subject has a previously documented diagnosis of ulcerative colitis (UC) with endoscopy and histology consistent with diagnosis * If female, the subject is at least 2 years postmenopausal or is surgically sterile per documentation provided by a third party medical professional or the subject agrees to use 2 highly effective methods of birth control during the study and is not pregnant or lactating * Subject is willing and able to comply with the study requirements * Subject has a body mass index (BMI) of \<32 kg/m2 * Subject has ulcerative colitis requiring treatment with 5-aminosalicylic acid (5-ASA) Exclusion Criteria: * Subject has undergone previous resective colonic surgery * Subject has previously diagnosed Crohn's Disease based on medical history * Subject has an extension of disease limited to ulcerative proctitis * Subject has active peptic ulcer disease based on medical history * Subject is currently being treated with any prescription medication except the following: A stable dose of 5-aminosalicylic acid (5-ASA) for at least 2 weeks, oral contraceptives or hormone replacement therapy (HRT) * Subject has a history of human immunodeficiency virus (HIV) * Subject has a history of severe allergic or anaphylactic reactions * Subject has a history of drug or alcohol abuse
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 65 Years
Study: NCT01320332
Study Brief:
Protocol Section: NCT01320332